ijms-logo

Journal Browser

Journal Browser

Molecular Targeted Therapy for Gliomas

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 20 January 2025 | Viewed by 1270

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Interests: molecular biology of brain tumour; neuroprotection in stroke; neurotrauma; medical education; medical law & ethics

Special Issue Information

Dear Colleagues,

The molecular signature of gliomas is now an integral part of the World Health Organisation (WHO) classification system of brain tumours, which provides powerful prognostic information. Despite advances in molecular targeting and innovative treatment approaches, tumour heterogeneity continues to pose daunting challenges, with individual tumours containing a spectrum of cellular subtypes which are able to transit between different cellular states. Combination treatment targeting different cellular vulnerabilities may serve as a promising approach to overcome tumour heterogeneity. However, the development of rational and effective therapeutic regimens is still impeded by inadequate insights into the mechanisms that govern glioma plasticity.

Supervised by Prof. Dr. Gilberto Ka-Kit Leung and assisted by our Topical Advisory Panel Member Dr. Karrie Mei Yee Kiang from The University of Hong Kong, this Special Issue “Molecular Targeted Therapy for Gliomas” of the International Journal of Molecular Sciences aims to introduce novel findings on glioma tumour biology in areas such as the identification of molecular targets; innovative tools or techniques on molecular profiling; and targeting approaches that would enhance treatment efficacy, overcome chemoresistance, and promote drug delivery, with a view to explore new avenues for glioma treatment.

Prof. Dr. Ka-Kit Leung
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • targeted therapy
  • glioma and glioblastoma
  • treatment strategies
  • identification of biomarkers
  • diagnosis
  • prognosis
  • molecular pathology
  • signalling pathways
  • molecular imaging
  • tumour microenvironment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 2547 KiB  
Article
Sirtuin 5 (SIRT5) Suppresses Tumor Growth by Regulating Mitochondrial Metabolism and Synaptic Remodeling in Gliomas
by Wanjun Tang, Bo Chen, Gilberto Ka-Kit Leung and Karrie M. Kiang
Int. J. Mol. Sci. 2024, 25(16), 9125; https://doi.org/10.3390/ijms25169125 - 22 Aug 2024
Viewed by 798
Abstract
Sirtuin 5 (SIRT5) is increasingly recognized as a key regulator of cellular metabolism, which is commonly dysregulated in cancer cells, resulting in enhanced proliferation and tumor progression. To investigate the clinicopathologic implications of SIRT5 dysregulation in glioblastoma, we performed comprehensive analyses of transcriptomic [...] Read more.
Sirtuin 5 (SIRT5) is increasingly recognized as a key regulator of cellular metabolism, which is commonly dysregulated in cancer cells, resulting in enhanced proliferation and tumor progression. To investigate the clinicopathologic implications of SIRT5 dysregulation in glioblastoma, we performed comprehensive analyses of transcriptomic data and functional verifications using in vitro and in vivo glioblastoma models. We found that higher SIRT5 expression levels were associated with a favorable prognosis in glioma patients. Knockdown of SIRT5 significantly enhanced glioblastoma cell growth. Our data suggest its potential role in regulating mitochondrial metabolism in gliomas. Furthermore, SIRT5 is also significantly correlated with synaptic remodeling pathways. Our findings indicate a tumor-suppressive role for SIRT5 that extends beyond regulating cancer metabolism, by which it may function through modulating neuroplasticity. Understanding these cellular interactions provides nuanced insights into the multifaceted role of SIRT5 and the broader therapeutic implications of this for the development of novel treatment strategies. Full article
(This article belongs to the Special Issue Molecular Targeted Therapy for Gliomas)
Show Figures

Figure 1

Back to TopTop